Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRRA | OCUL | AVDL | ||
| Company | Sierra Oncology Inc | Ocular Therapeut | Avadel Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.98 | 8.94 | 13.83 | ||
| High | 55.17 | 9.14 | 14.10 | ||
| Low | 54.98 | 8.63 | 13.59 | ||
| Last | 54.99 | 9.05 | 13.65 | ||
| Change | +0.02 | +0.29 | -0.18 | ||
| % Change | +0.04% | +3.31% | -1.30% | ||
| Volume | 862,800 | 1,479,700 | 911,800 | ||
| 20-Day Average Volume | 396,690 | 790,410 | 1,020,425 | ||
| Previous Close | 54.97 | 8.76 | 13.83 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.91 | 8.75 | 14.81 | ||
| 20-Day Raw Stochastic | 62.96% | 73.33% | 6.07% | ||
| 20-Day Relative Strength | 77.35% | 58.87% | 36.17% | ||
| Weighted Alpha | +89.10 | +155.82 | +8.18 | ||
| Today's Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 06/23/22 | +7.23% since 09/11/24 | unch since 09/11/24 | ||
| Low | 54.65 on 06/24/22 | 8.37 on 09/12/24 | 13.53 on 09/12/24 | ||
| High | 55.19 on 06/24/22 | 9.14 on 09/18/24 | 14.25 on 09/12/24 | ||
| 1-Month | |||||
| %Chg | +0.38% since 05/27/22 | +11.59% since 08/16/24 | -14.37% since 08/16/24 | ||
| Low | 54.58 on 05/31/22 | 8.11 on 08/19/24 | 13.46 on 09/11/24 | ||
| High | 55.19 on 06/24/22 | 9.39 on 08/22/24 | 16.59 on 08/23/24 | ||
| 3-Month | |||||
| %Chg | +69.83% since 03/30/22 | +64.85% since 06/18/24 | -12.50% since 06/18/24 | ||
| Low | 30.87 on 03/31/22 | 5.89 on 06/20/24 | 13.42 on 06/28/24 | ||
| High | 55.19 on 06/24/22 | 9.39 on 08/22/24 | 17.30 on 08/08/24 | ||
| 6-Month | |||||
| %Chg | +144.40% since 12/30/21 | -4.13% since 03/18/24 | -13.44% since 03/18/24 | ||
| Low | 14.91 on 01/24/22 | 4.06 on 04/26/24 | 13.42 on 06/28/24 | ||
| High | 55.19 on 06/24/22 | 10.28 on 03/21/24 | 19.09 on 05/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,342,801 | 1,356,828 | 1,329,326 | ||
| Shares Outstanding, K | 24,419 | 154,889 | 96,119 | ||
| Annual Sales | 0 | 58,440,000 | 27,960,000 | ||
| Annual Net Income | -94,660,000 | -80,740,000 | -160,280,000 | ||
| Last Quarter Sales | 0 | 16,440,000 | 41,500,000 | ||
| Last Quarter Net Income | -27,930,000 | -43,780,000 | -13,820,000 | ||
| 60-Month Beta | 0.01 | 1.28 | 1.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.33 on 05/06/22 | -0.24 on 08/07/24 | -0.14 on 08/08/24 | ||
| Latest Earnings Date | 08/04/22 | 11/05/24 | 08/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||